Affiliation: University of Texas at Arlington
- A cognitive/behavioral group intervention for weight loss in patients treated with atypical antipsychoticsMary Weber
School of Nursing, The University of Texas at Arlington, 411 S Nedderman Dr Box 19407, 76019 0407, USA
Schizophr Res 83:95-101. 2006..6% body weight. The range of weight loss for the treatment group was from 1 to 20 lb. This pilot study has demonstrated that weight loss is possible with cognitive/behavioral interventions in a population with a psychotic disorder...
- An introductory clinical core course in psychiatric management: an innovative lifespan course blending all nurse practitioner majorsMary T Weber
Arlington School of Nursing, VA, USA
Perspect Psychiatr Care 42:245-51. 2006..Nonpsychiatric nurse practitioners must be able to recognize symptoms of common psychiatric disorders, know how to treat less complex mental illnesses, and know when to refer to psychiatric mental health nurse practitioners (PMHNPs)...
- Pilot study of a cognitive behavioral group intervention to prevent further weight gain in Hispanic individuals with schizophreniaMary Weber
School of Nursing, University of Texas at Arlington, Arlington, Texas
J Am Psychiatr Nurses Assoc 13:353-9. 2008..In the Diabetes Prevention Project (DPP), cognitive-behavioral (CB) interventions were more effective in reducing weight and preventing diabetes...
- Glucose metabolism in patients with schizophrenia treated with atypical antipsychotic agents: a frequently sampled intravenous glucose tolerance test and minimal model analysisDavid C Henderson
Schizophrenia Program, Massachusetts General Hospital, Boston, MA, USA
Arch Gen Psychiatry 62:19-28. 2005....
- Triggers for self-abuse: a qualitative studyMary T Weber
University of Texas at Arlington, School of Nursing, Arlington, TX 76019-0407, USA
Arch Psychiatr Nurs 16:118-24. 2002..Specific triggers were identified as well as suggested nursing interventions...
- Treatment and prevention of obesity: what works, what doesn't work, and what might workDavid B Allison
Department of Biostatistics, Section on Statistical Genetics and Clinical Nutrition Research Center, University of Alabama at Birmingham, Alabama 35294 0022, USA
Lipids 38:147-55. 2003..Perhaps, with continued efforts at enhancing treatments, we will see incremental advances in the treatment and prevention of obesity...
- An open-label trial of quetiapine for antipsychotic-induced sexual dysfunctionMatthew J Byerly
University of Texas Southwestern Medical Center at Dallas, Dallas, Texas 75390 9101, USA
J Sex Marital Ther 30:325-32. 2004..03). Plasma prolactin levels tended to decrease after the transition to quetiapine (p = 0.09). Quetiapine appears to offer an option to reduce antipsychotic-induced sexual dysfunction for outpatients with schizophrenia...